ID
45891
Descripción
Principal Investigator: Carl Morrison, MD, DVM, Roswell Park Cancer Institute, Buffalo, NY, USA MeSH: Granular Cell Tumor https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000978 We report one case study of a malignant granular cell tumor patient with metabolic response to pazopanib. In this study, we used whole-genome sequencing of the tumor with the matched blood to characterize the somatic mutation profile in this tumor. This is the first reported whole-genome sequencing study of the rare malignant granular cell tumor.
Link
Palabras clave
Versiones (1)
- 1/12/23 1/12/23 - Simon Heim
Titular de derechos de autor
Carl Morrison, MD, DVM, Roswell Park Cancer Institute, Buffalo, NY, USA
Subido en
1 de diciembre de 2023
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
dbGaP phs000978 WGS of a malignant GCT with metabolic response to pazopanib
Subject ID, sample ID, sample source, source sample ID, and sample use variable of participant with malignant granular cell tumor and involved in the "Whole-Genome Sequencing (WGS) of a Malignant Granular Vell Tumor (GCT) with Metabolic Response to Pazopanib" project.
- StudyEvent: SEV1
- Subject ID, consent group, subject source, source subject ID, and affection status of participant with malignant granular cell tumor and involved in the "Whole-Genome Sequencing (WGS) of a Malignant Granular Vell Tumor (GCT) with Metabolic Response to Pazopanib" project.
- Subject ID, sample ID, sample source, source sample ID, and sample use variable of participant with malignant granular cell tumor and involved in the "Whole-Genome Sequencing (WGS) of a Malignant Granular Vell Tumor (GCT) with Metabolic Response to Pazopanib" project.
- Sample ID, body site where sample was obtained, analyte type, tumor status of sample, histological type, primary tumor location, tumor stage, tumor grade, tumor treatment, genotyping center, sequencing center of participant with malignant granular cell tumor and involved in the "Whole-Genome Sequencing (WGS) of a Malignant Granular Vell Tumor (GCT) with Metabolic Response to Pazopanib" project.
Similar models
Subject ID, sample ID, sample source, source sample ID, and sample use variable of participant with malignant granular cell tumor and involved in the "Whole-Genome Sequencing (WGS) of a Malignant Granular Vell Tumor (GCT) with Metabolic Response to Pazopanib" project.
- StudyEvent: SEV1
- Subject ID, consent group, subject source, source subject ID, and affection status of participant with malignant granular cell tumor and involved in the "Whole-Genome Sequencing (WGS) of a Malignant Granular Vell Tumor (GCT) with Metabolic Response to Pazopanib" project.
- Subject ID, sample ID, sample source, source sample ID, and sample use variable of participant with malignant granular cell tumor and involved in the "Whole-Genome Sequencing (WGS) of a Malignant Granular Vell Tumor (GCT) with Metabolic Response to Pazopanib" project.
- Sample ID, body site where sample was obtained, analyte type, tumor status of sample, histological type, primary tumor location, tumor stage, tumor grade, tumor treatment, genotyping center, sequencing center of participant with malignant granular cell tumor and involved in the "Whole-Genome Sequencing (WGS) of a Malignant Granular Vell Tumor (GCT) with Metabolic Response to Pazopanib" project.
C0449416 (UMLS CUI [1,2])
C2347026 (UMLS CUI [1,3])
C3847505 (UMLS CUI [1,2])
C0449416 (UMLS CUI [1,3])